121 related articles for article (PubMed ID: 7846687)
1. Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma.
Sato K; Terada K; Sugiyama T; Takahashi S; Saito M; Moriyama M; Kakinuma H; Suzuki Y; Kato M; Kato T
Tohoku J Exp Med; 1994 Jul; 173(3):355-60. PubMed ID: 7846687
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma].
Sato K; Kato T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):389-94. PubMed ID: 9063473
[TBL] [Abstract][Full Text] [Related]
3. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
4. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
Siemeister G; Weindel K; Mohrs K; Barleon B; Martiny-Baron G; Marmé D
Cancer Res; 1996 May; 56(10):2299-301. PubMed ID: 8625303
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas.
Hemmerlein B; Kugler A; Ozisik R; Ringert RH; Radzun HJ; Thelen P
Virchows Arch; 2001 Nov; 439(5):645-52. PubMed ID: 11764385
[TBL] [Abstract][Full Text] [Related]
6. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ
Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression.
Lee JS; Kim HS; Jung JJ; Park CS; Lee MC
J Surg Oncol; 2001 May; 77(1):55-60. PubMed ID: 11344484
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.
Tsuchiya N; Sato K; Akao T; Kakinuma H; Sasaki R; Shimoda N; Satoh S; Habuchi T; Ogawa O; Kato T
Tohoku J Exp Med; 2001 Oct; 195(2):101-13. PubMed ID: 11846206
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases.
Zhang X; Yamashita M; Uetsuki H; Kakehi Y
Int J Urol; 2002 Sep; 9(9):509-14. PubMed ID: 12410931
[TBL] [Abstract][Full Text] [Related]
11. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor expression is increased in renal cell carcinoma.
Nicol D; Hii SI; Walsh M; Teh B; Thompson L; Kennett C; Gotley D
J Urol; 1997 Apr; 157(4):1482-6. PubMed ID: 9120987
[TBL] [Abstract][Full Text] [Related]
15. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma.
Thelen P; Hemmerlein B; Kugler A; Seiler T; Ozisik R; Kallerhoff M; Ringert RH
Anticancer Res; 1999; 19(2C):1563-5. PubMed ID: 10365146
[TBL] [Abstract][Full Text] [Related]
16. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.
Takahashi A; Sasaki H; Kim SJ; Tobisu K; Kakizoe T; Tsukamoto T; Kumamoto Y; Sugimura T; Terada M
Cancer Res; 1994 Aug; 54(15):4233-7. PubMed ID: 7518352
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma.
Tomisawa M; Tokunaga T; Oshika Y; Tsuchida T; Fukushima Y; Sato H; Kijima H; Yamazaki H; Ueyama Y; Tamaoki N; Nakamura M
Eur J Cancer; 1999 Jan; 35(1):133-7. PubMed ID: 10211101
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor-b in human astrocytoma.
Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C
Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624
[TBL] [Abstract][Full Text] [Related]
19. Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma.
Nakagawa M; Emoto A; Hanada T; Nasu N; Nomura Y
Br J Urol; 1997 May; 79(5):681-7. PubMed ID: 9158500
[TBL] [Abstract][Full Text] [Related]
20. [Cancer therapy targeting tumor-induced neovascularization].
Sato K; Kato T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):295-300. PubMed ID: 7509149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
